{"id":"https://openalex.org/W4361876743","doi":"https://doi.org/10.1158/0008-5472.22421699","title":"Supplementary Methods and References from HER2 Overexpression Triggers an IL1\u03b1 Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance","display_name":"Supplementary Methods and References from HER2 Overexpression Triggers an IL1\u03b1 Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361876743","doi":"https://doi.org/10.1158/0008-5472.22421699"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22421699","doi":"https://doi.org/10.1158/0008-5472.22421699","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22421699","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_and_References_from_HER2_Overexpression_Triggers_an_IL1_Proinflammatory_Circuit_to_Drive_Tumorigenesis_and_Promote_Chemotherapy_Resistance/22421699/1/files/39867884.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_and_References_from_HER2_Overexpression_Triggers_an_IL1_Proinflammatory_Circuit_to_Drive_Tumorigenesis_and_Promote_Chemotherapy_Resistance/22421699/1/files/39867884.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111656492","display_name":"Shou Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shou Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079522224","display_name":"Ji Shin Lee","orcid":"https://orcid.org/0000-0003-4634-2228","observed_orcids":["https://orcid.org/0000-0003-4634-2228"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji Shin Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069829773","display_name":"Chunfa Jie","orcid":"https://orcid.org/0000-0003-4838-5168","observed_orcids":["https://orcid.org/0000-0003-4838-5168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunfa Jie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041704574","display_name":"Min Ho Park","orcid":"https://orcid.org/0000-0003-1504-3815","observed_orcids":["https://orcid.org/0000-0003-1504-3815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Ho Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074919264","display_name":"Yoichiro Iwakura","orcid":"https://orcid.org/0000-0002-9934-5775","observed_orcids":["https://orcid.org/0000-0002-9934-5775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoichiro Iwakura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017699573","display_name":"Yogin K. Patel","orcid":"https://orcid.org/0000-0002-1951-009X","observed_orcids":["https://orcid.org/0000-0002-1951-009X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yogin Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029164728","display_name":"Mithil K. Soni","orcid":"https://orcid.org/0000-0001-9387-0221","observed_orcids":["https://orcid.org/0000-0001-9387-0221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mithil Soni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017253679","display_name":"David Reisman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Reisman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5114375978","display_name":"Hexin Chen","orcid":"https://orcid.org/0000-0001-9300-0859","observed_orcids":["https://orcid.org/0000-0001-9300-0859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hexin Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":1.0},{"id":"https://openalex.org/keywords/interleukin-1-alpha","display_name":"interleukin-1 alpha","score":0.8519999980926514},{"id":"https://openalex.org/keywords/carcinogenesis","display_name":"carcinogenesis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9919999837875366},{"id":"https://openalex.org/keywords/crispr-cas9","display_name":"CRISPR/Cas9","score":0.8190000057220459},{"id":"https://openalex.org/keywords/chromatin-immunoprecipitation","display_name":"chromatin immunoprecipitation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/gene-expression-microarrays","display_name":"gene expression microarrays","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.6019982695579529},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5804516673088074},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5207733511924744},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.5059050917625427},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46101394295692444},{"id":"https://openalex.org/C186836561","wikidata":"https://www.wikidata.org/wiki/Q1931516","display_name":"Microarray","level":4,"score":0.4314260482788086},{"id":"https://openalex.org/C22744801","wikidata":"https://www.wikidata.org/wiki/Q172778","display_name":"Plasmid","level":3,"score":0.427446186542511},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.42697271704673767},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4084581136703491},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3371308445930481},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1897919476032257},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.14719828963279724},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13040879368782043},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08478942513465881},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.06910410523414612}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22421699","doi":"https://doi.org/10.1158/0008-5472.22421699","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22421699","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_and_References_from_HER2_Overexpression_Triggers_an_IL1_Proinflammatory_Circuit_to_Drive_Tumorigenesis_and_Promote_Chemotherapy_Resistance/22421699/1/files/39867884.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22421699.v1","doi":"https://doi.org/10.1158/0008-5472.22421699.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22421699.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22421699","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_and_References_from_HER2_Overexpression_Triggers_an_IL1_Proinflammatory_Circuit_to_Drive_Tumorigenesis_and_Promote_Chemotherapy_Resistance/22421699","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22421699","doi":"https://doi.org/10.1158/0008-5472.22421699","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22421699","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_and_References_from_HER2_Overexpression_Triggers_an_IL1_Proinflammatory_Circuit_to_Drive_Tumorigenesis_and_Promote_Chemotherapy_Resistance/22421699/1/files/39867884.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361876743.pdf","grobid_xml":"https://content.openalex.org/works/W4361876743.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W2060932390","https://openalex.org/W2096439168","https://openalex.org/W2143383125"],"related_works":["https://openalex.org/W4361824949","https://openalex.org/W2797521429","https://openalex.org/W4392724474","https://openalex.org/W2103315206","https://openalex.org/W2741195018","https://openalex.org/W3147818471","https://openalex.org/W1588561799","https://openalex.org/W7130848277","https://openalex.org/W3004443336","https://openalex.org/W6893055701"],"abstract_inverted_index":{"Supplementary":[0,5],"methods":[1,6],"and":[2,30],"References":[3],"-":[4],"describing":[7],"key":[8],"reagents,":[9],"plasmids,":[10],"cell":[11],"culture,":[12,23],"CRISP/Cas9":[13],"system,":[14],"HER2":[15],"agonist":[16],"preparation,":[17],"RT-PCR,":[18],"western":[19],"blot,":[20],"flow-cytometry,":[21],"tumorsphere":[22],"ChIP":[24],"assay,":[25],"animal":[26],"experiments,":[27],"Immunohistochemically":[28],"staining":[29],"microarray":[31],"analysis.":[32]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}